BioPlus Co. Ltd. (099430) Q2 2024 Earnings Report
KR:099430 Q2 2024 EPS Results
- Actual EPS
- KRW 97.60
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- KRW 127.31
KR:099430 Q2 2024 Revenue Results
- Actual Revenue
- KRW 11.29B
- Expected Revenue
- KRW 9.90B
- Beat/Miss
- Beat by +KRW 1.39B
- YoY Revenue Growth
- -40.44%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/14/2024
- Time
- TBA
- Conference Call
- Wednesday, August 14, 2024
KR:099430 Upcoming Earnings
BioPlus Co. Ltd.'s next earnings date is estimated for November 18, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
KR:099430 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 18, 2026 | 2026 (Q3) | ―- | 52.75 | ― | ― |
| Aug 14, 2026 | 2026 (Q2) | ―33.18 | 37.12 | -10.60% (-3.93) | |
| May 14, 2026 | 2026 (Q1) | ―109.12 | 133.06 | -17.99% (-23.94) | |
| Mar 20, 2026 | 2025 (Q4) | ―32.55 | 53.85 | -39.55% (-21.30) | |
| Nov 14, 2025 | 2025 (Q3) | ―52.75 | 58.11 | -9.22% (-5.36) | |
| Aug 14, 2025 | 2025 (Q2) | ―37.12 | 97.6 | -61.97% (-60.49) | |
| May 14, 2025 | 2025 (Q1) | ―133.06 | 39.25 | 239.00% (+93.81) | |
| Feb 13, 2025 | 2024 (Q4) | ―53.85 | 117.14 | -54.03% (-63.29) | |
| Nov 14, 2024 | 2024 (Q3) | ―58.11 | 96.08 | -39.52% (-37.97) | |
| Aug 14, 2024 | 2024 (Q2) | ―97.60 | 127.31 | -23.33% (-29.70) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
